chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A report was received from a healthcare professional on 17th November 2005, regarding a female vaccinee aged 32-40 years old. No details were provided regarding the vaccinee's medical history or concomitant medications. On 17th November 2005, the vaccinee received a Fluvirin vaccination intramuscularly,. Within 20 minutes the vaccinee experienced extreme flushing of the face, itching on her back, flushing, wooziness, shaking and sweating. The vaccinee did not go to hospital, but an observer said that she probably should have gone. The outcome of the vaccinee was unknown at the time of reporting. Follow up information received on 23rd November 2005 reported that the vaccinee returned to the site experiencing dizziness and feeling hot. Her blood pressure was checked at 12:30 pm the reading was 180/120, pulse 112-120. 911 was called. The vaccinee blood pressure was checked again and was 160/100, pulse 115. It was suggested that the vaccinee should go to her doctor. The vaccinee state that she felt like a migraine headache coming on. The vaccinee was not taken to hospital.
Large area on upper left arm: redness swelling, intense itching. Told to take tylenol and Benadryl.
Very high fever of 103, peaking at over 104 for a solid 48 hrs. Fever came down a bit with Motrin. Trip to ER inconclusive as far as the cause of his symptoms. MMR shot was brushed off by Doctors as not a possible cause for fever. Child also experienced extreme fussiness for days after fever broke and lost some of his ability to balance. Stopped walking as much as he was able to before shot and was more clumsy/fell more. Started before fever. Tiny little red spots also appeared on trunk and face in conjunction with fever. Not it hwy of painful.
Severe dizziness cuasing inability to walk without assistance occurred approximately 4 hours post administration of vaccination.  Dizziness so severe resulted in vomitting, visit to ED followed by 2 full days in bed and while symptoms have improved substantially, dizziness still present 4 days post receipt of vaccine.
Started to notice heart racing or heart palpitations and on 04/14/2021 went to a walk in clinic because I was uncomfortable.  They found noting serious.  Went to my Dr and she sent me for Holter monitor which showed no heart damage.  As time has gone by the palpitations have subsided and gone away.  I am not bothered on a daily basis with them.   I am wondering if and when a booster is available should I get one??
Site reaction. Red and swollen. Reaction went away 3 days later but has just returned 7 days post injection
I  noticed  a rash on my belly and bilateral arms like a small red spot ( like mosquito bite ) in the morning of March 18 bug  it wasn?t itching . I wait for few days before getting help ; however , after   5 days I noticed the rash was getting worse . I consult a nurse practitioner at my dr office who prescribe Claritin  , Pepside   1 pill a day . She also gave me a cream  named permethrin and I used it but it didn?t resolve . I went back to my primary doctor and he suspected I may have pityriasis rósea. He gave suggested me to take the second COvid vaccine which is due tomorrow  but I?m afraid  because he is not sure the rash wasn?t caused by the vaccine. He also prescribed me MethylPrednisolone via oral to help with the rash. My belly , back and bilateral arms are full of rash . I have some on my tights too. I read about some people getting skin reaction  on n from the Vaccine and I?m not sure if that is happing to me now but I feel it is very important to report so we can figure out about this vaccine and side effects together . Please feel free to call me at anytime
Pt states he has been unable lift arm more than 90' due to pain that still remains in shoulder of arm where shot was given. It remains 3-4 weeks after vaccine w/slight improvement. Had seen doctor. Doctor also gave him flu shot, in other arm, and the same thing is happening in that arm, too. Pt told to watch and wait.
Quarter- size red macules at site of injection - left thigh. Slowly lumping as of 12/10/06 - redness decrease.
1/7/2021 vaccination 1/8/2021 bruise/pain R lower leg, hard warm to touch. Painful and sore.  Progressively got worse; red, bluer.  1/10 or 1/11 ER . Ultra sound on leg. 10cm clot. Put me on aspirin, warm compresses. Had to increase aspirin up to 2x day. It eventually cleared. Referred to surgeon. Found some other veins their inspecting further.  *have not had any more clots
pt tested positive for COVID on 8/23/21; received monoclonal antibodies; treated with antibiotics and Decadron; pt's condition worsened and she became bedridden; increasing weakness and poor po intake; condition continued to deteriorate; family opted to stop aggressive therapy and place pt in hospice with comfort care measures; pt died at home per death certificate
pt recv vax & c/o sense of numbness which was localized to both elbows;also had a sense of flushing of face;
Fever sore throat headache muscle ache fatigue chills Swollen lymph nodes breast ache and injection site tenderness after 24 hours. Lasted 48 hours then swollen lymph nodes and pain under arm that received injection. Swollen lymph nodes and pain moved from under the arm to elbow. Now severe pain in left arm AC region extending to wrist. Hand numb and weak. Headaches nose bleed.
Patient describes feeling vertigo from first shot. She said it progressively got better until she received her second shot. She is reporting it is worse today (the day after her second shot).
Had first GARDASIL shot. Passed out and had seizure for approximately sixty seconds. When awoke blood pressure low 60/45. Vomited. After thirty minutes blood pressure back up to 65/50. Ten minutes after that BP was 70/50. Shot was done at MD office by RN. No issue during shot or immediately after. Walked back to waiting room sat down and passed out a few minutes later. Normal blood pressure is 110/80.
Left arm soreness dissipated after 1st week, came back today (mild but apparent) with NEW spasms in hand/thumb
Persistent, unconsolable cry /p DPT for 3 to 4 hrs
patient had tingling in mouth and metallic taste following immunization. Patient was better after approximately 15 minutes.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 20-JAN-2014, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J008433 and expiry date: 11-OCT-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Vaccines admin. 4-1-08, that night pt. c/o soreness of arms.  4-2-08 very tired, achy.  4-3-08 L arm quivering, achy, soreness, nausea and headache.  4-4-08 headache, jaw pain, low grade temp 100.  Pt. stated head is "splitting".  Prone to headaches.  Rx with Imitrex.  hx mono 9-07.  Lab ordered CBC, sed rate.
Patient experienced headache, soreness, chills, nausea and fever shortly after her vaccination.
mo of pt phoned 16APR91 to report that pt was dragging leg & unable to walk; p/consulting w/RN was referred to MD; MD felt should wait 2 wks; no improvement x-ray revealed fluid in rt hip;
No additional AE/PQC reported; an expired dose of M-M-R II was given to a patient; This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On 26-JAN-2021, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) lot # R035704, expiration date:09-DEC-2020 (dose, route of administration and anatomical location were not reported) for prophylaxis. There were no know temperature excursions. No adverse event was reported.
Had weakness, fatigue, sleepiness and external mouth tightness (like she had "chapped lips") for 5-10 minutes after the vaccine. Denies throat tightness.
Rt arm became warm, swollen, rash at injection site then turned to bruise by 11/23/2009.
Vaccine received 2-27, developed sore arm that night, woke next morning with chills and developed temperature 102.2-103 when checked, poor appetite and weak, slept most of day. Felt better until woke in the night on  3-3-21 with chest pain, unable to get comfortable, no relief with ibuprofen, some relief with aspirin. Pain persisted next day on 3-4-21 so seen in Emergency room and diagnosed with pericarditis and 2 pulmonary emboli.
This patient came into the pharmacy on 10/24/18 to let us know she was still experiencing pain in her left arm in which she received the FLUAD vaccination in on 10/17/18. She was having twitching in the muscle and experiencing what she described as a wrenching pain, with or without movement. She did not have any redness, swelling or warmth at the injection site. She did not have numbness or tingling in her arms or fingers. She had not taken any acetaminophen or ibuprofen, nor did she apply any heat or cold compresses to the site. Her main concern was that she wanted to know how long she should expect the pain to continue for. I recommended that she try ibuprofen and heat to see if she would get some relief.
Initial report received on 01 March 2007 from another manufacturer, no report number provided. The initial reporter to this manufacturer had been a health care professional. A 22-year-old female patient had received an injection of Influenza Vaccine, manufacturer reported, lot number not reported; in November 2006. On an unspecified date post-immunization in November 2006, the patient developed an anaphylactic reaction which required medical attention. The patient had also received an injection of Gardasil in October 2006 with "no incident." Additionally medically relevant information was not provided.
This spontaneous report as received from a consumer refers to a 69 year old female patient with seasonal allergies. On 30-AUG-2012 the patient was vaccinated with ZOSTAVAX (lot number, expiry date, dose, frequency, route unspecified). Concomitant therapies included unspecified medication for blood pressure, cholesterol, thyroid and "arthritis" (manufacturers and doses unspecified). On 10-JUL-2013, the patient developed shingles. The patient reported that she had a breakout of shingles on her face. The patient sought medical attention via office visit and was diagnosed by her primary physician. No laboratory diagnosis studies were performed. The outcome of the event was reported as not recovered/not resolved at reporting time. Additional information has been requested.
Inappropriate schedule of vaccine administered; sick; don't have appetite; cold flu; headache; The initial case was missing the following minimum criteria: [specify criteria (e.g., no suspect product)]. Upon receipt of follow-up information on [29Jun2021], this case now contains all required information to be considered valid. This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75 year-old female patient received bnt162b2 (BNT162B2), administration date 24May2021 (Lot number: EW0179) at the age of 75 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "inflamed ulcer" (unspecified if ongoing); "colon problems" (unspecified if ongoing); "colon procedure", start date: 26Mar2021 (unspecified if ongoing); "bowel obstruction", start date: 1990 (unspecified if ongoing); "nervousness" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "stomach problems" (unspecified if ongoing); "trembling" (unspecified if ongoing); "diabetic" (unspecified if ongoing), notes: My concern is I am 80 and diabetic,. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number-1), administration date: 07May2021, when the patient was 75 years old, for Covid-19 immunization, reaction(s): "sick". The following information was reported: ILLNESS (non-serious) with onset May2021, outcome "unknown", described as "sick"; DECREASED APPETITE (non-serious) with onset May2021, outcome "unknown", described as "don't have appetite"; INFLUENZA (non-serious) with onset May2021, outcome "unknown", described as "cold flu"; HEADACHE (non-serious) with onset May2021, outcome "unknown", described as "headache"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 24May2021, outcome "unknown", described as "Inappropriate schedule of vaccine administered".  Additional information: It was reported that, consumer stated ok I am trying to get help, I have been sick after getting the shot, maybe I am calling the wrong place, I have get both of my shots. Consumer stated, I am trying to get to the doctor the find out because I have been sick for 2 weeks. Consumer stated, My concern is I am 80 and diabetic, I am not eating I don't have appetite, it's like the cold flu, it's like the flu that's what I am saying, headache, I was already sick when I took the shot. Consumer stated, I would like to say thanks that I am alive today, I have been able to witness. I have been going through a lot of different sicknesses but I have gone through them and do the right thing.  No follow-up attempts are possible. No further information is expected.
low grade fever started early morning after vaccine. then went up yo a high fever 102.6 around 2pm. acetaminophen seems to bring it down. then became elevated again in the evening.  enlarged lymph node in armpit of arm with vaccine, started 48hrs after shot.  these have all happened with the booster (2nd shot) for both sten
PT ADVISED THAT HE VOMITTED FROM HIS LAST COVID19 VACCINE. PT HAD THE SAME REACTION WITH THE 2ND DOSE FROM THE PFIZER COVID 19 VACCINE. PT VOMITED X 2.
little bit achy and achiness type stuff; normal low energy; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number was not reported) on an unspecified date as first dose for covid-19 immunisation. On an unspecified date, the patient experienced little bit achy, and the achiness type stuff, and had normal low energy. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a medical assistant concerning a 26 year old female with possible peptic ulcer, depression, no drug allergies, and a history of anxiety, "gerd", two "terminations" and one knee surgery who on 23-JUL-2009 was vaccinated with a first dose of GARDASIL (Lot No. 661046/0381X). Concomitant therapy included METROGEL, clonazepam and "birth control". Since the patient received her first dose of GARDASIL her whole arm was blotchy, she had mood swings, shoulder pain, hand numbness, and vaginal irritation and discharge. The office medical assistant stated that on 02-OCT-2009 the patient informed she was not going to receive any more doses of GARDASIL. At the time of the report, the outcome of the patient was unknown. Follow up information was received from the nurse who indicated that the patient with a history of bacterial vaginosis on 23-JUL-2009 was vaccinated with a first dose of GARDASIL (Lot No. 661046/0381X) in her left deltoid. Concomitant therapy included KLONOPIN, YASMIN and PERCOCET. Subsequently the patient developed vagina swollen. She sought medical attention for vaginal irritation and discharge. The patient was not recommended to receive the second and third dose of GARDASIL. The outcome of the patient was not reported. No further information is available.
Initial report was retrieved from the scientific literature on 06 September 2012. The following information is verbatim from the abstract: "Meningococcal have historically caused extensive illness among members. Three successive meningococcal vaccine types were used from 1971 through 2010; overall disease incidence dropped by >90% during this period. During 2006-2010, disease incidence of 0.38 (cases per 100,000 person-years) among members was not significantly different from the incidence of 0.26 among the age-matched general population. Of the 26 cases, 5 were fatal, 15 were vaccine failures (e.g., illness in a person who had been vaccinated), and 9 were caused by Neisseria meningitidis serogroup Y. Incidences among 17- to 19-year-old basic trainees and among were significantly higher than among comparison populations (p<0.05). No apparent change in epidemiology of meningococcal disease was observed after replacement of quadrivalent polysaccharide vaccine with conjugate vaccine in 2007. The data demonstrate that vaccination with meningococcal vaccine is effective." According to the report, the cases were confirmed by culture, PCR or both. The information included in this case concerns a 20-24 year-old male patient who had received MENOMUNE A/C/Y/W-135 (lot number, route, site and date of administration not reported) and 12 months after vaccination developed meningococcal meningitis and sepsis, year reported as 2006 (Q 1). Neisseria meningitidis serogroup was determined to be serogroup C. Treatments were not reported. No further information was available at the time of report. The patient's outcome was fatal (date of death not reported). The reporter for this case is the same as for cases 2012-08241, -08242, -08243, -08244, -08245, -08246, -08247, -08248, -08249, -08250, -08251, -08252, -08253, -08254, -08255, and -08256. Documents held by sender: None.
Chills, muscle aches, fever, body aches, headache. Lasted for 2 days afterwards.
Patient's right arm was immediately very sore (Pneumovax 23). He stated that night he was very restless and had constant nightmares. He woke up shivering, had trouble walking, unsteady and dizzy. His wife prevented a near fall from the dizziness when he was getting up. He stated today 5/5/2022 he is still a bit groggy and unsteady, but is feeling much better.
having weight issues, probably a little bit because of what was going on. Dropped 10lbs to 12lbs in the past couple months; Severe diarrhea 3 days after that dose that lasted for 2.5 weeks/ diarrhea returned 3 dayts later and is still persisting This is a spontaneous report from Pfizer. A contactable female consumer reported for herself. A 62-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL9261; Expiration Date: 31May2021), dose 1 via an unspecified route of administration on 21Jan2021 as single dose, and dose 2 via an unspecified route of administration on 11Feb2021 (Batch/Lot Number: EK4176; Expiration Date: 31May2021) as dose 2, single (at the age of 62-year-old) for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included famotidine 20 mg taken for stomach pain from 14Jan2021 to an unspecified stop date. Caller reported that she received the first dose of the Pfizer Covid 19 vaccine on 21Jan2021 and experienced severe diarrhea on 24Jan2021, 3 days after first dose that lasted for 2.5 weeks. Started to get better and had two days that were relatively normal. Then she received the second dose on 11Feb2021 and the diarrhea returned 3 days later and was still persisting. It has been five weeks now of diarrhea. She also stated that sometimes the diarrhea would get a little better, but sometimes it would come back really bad. She was having weight issues, probably a little bit because of what was going on. Dropped 10lbs to 12lbs in the past couple months. She was usually between 118-120lbs, but now is about 108lbs. She reported that before the first COVID vaccine, she had been taking Famotidine for a week for stomach pain that she has been having for a long time. Stated maybe that was it. Stopped Famotidine on the 11th day. Was on Famotidine for a full week before symptoms came up. Has stopped the Famotidine and it never went away. Hadn't taken Famotidine for almost five weeks now. The patient underwent lab tests and procedures which included clostridium test (C-diff) and helicobacter test which was negative on an unspecified date. She was taking Imodium to stop it. The outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Sudden fever 100 degrees, 26 hours post vaccine Eyes sensitive to light Migraine  Raised red area, 3? oval, appeared 24 hours post vaccine Nausea Rapid heart beat, elevated blood pressure
This spontaneous report as received from a registered nurse refers to a multiple unspecified patients of unknown age and gender. Pertinent medical history, drug reactions or allergies were not reported. On an unkonwn date, multiple unspecified patients were vaccinated with RECOMBIVAX HB (dose, dose number, route, anatomical location, lot number and expiration were unspecified), after the vaccines were exposed to temperatures from outside of recommended condition. No adverse events were reported. No concomitant therapies were reported. The outcome of the events was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
Starting 12/16, she had experienced fever, headache and nausea, as well as local arm pain.
Pt had a muscle ache - bad - according to patient. lasted for 6 days after the vaccination
Discomfort; Tinnitus; This case was reported by a consumer via call center representative and described the occurrence of tinnitus in a 54-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th January 2020, the patient received the 1st dose of Shingrix. In February 2020, less than 2 months after receiving Shingrix, the patient experienced tinnitus. On an unknown date, the patient experienced discomfort. On an unknown date, the outcome of the tinnitus was recovering/resolving and the outcome of the discomfort was recovered/resolved.   It was unknown if the reporter considered the tinnitus and discomfort to be related to Shingrix.  Additional details were reported as follows: In mid February 2020, patient developed Tinnitus. He stated that he thought it may have been caused by Shingrix and was inquired about the same.  The patient stated that he still experiences tinnitus on and off and that some days were better than others. He also stated that the first dose of Shingrix was not that bad in the sense that he only felt a little discomfort afterward. The reporter consented to follow up. The outcome for event discomfort was reported as recovered/resolved with sequel however it was captured as recovered/resolved in the case.
Swelling, erythema of upper left arm, 6cm x 7cm in size, induration, no fever.